Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Knowing the average retirement savings for 30-year-olds helps gauge your financial health. Learn the benchmarks to aim for as you save.
23,529 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Two New York teens, ages 18 and 19, were arrested after an alleged explosives incident at a counter-protest near the ...
Binance filed a defamation lawsuit against The Wall Street Journal in New York, challenging a February report on Iran...
Solana is under renewed selling pressure as negative funding rates persist and on-chain inflows surge. Analysts warn ...
A landmark U.S. refinery plan in Brownsville is unveiled but its first fuel production won’t come for years, leaving ...
Evergreen demand makes certain stocks thrive through booms and busts. Learn how these consumer staples stocks stay re...
Fidelis Investors closes a $144 million RTL securitization, its third, backing 330 rehab loans across 29 lenders. The...
A surge of commentary in crypto circles centers on XRP's function within Ripple's rails, pitting advocates of open fi...
earnings week brings big questions for Micron. The real driver isn’t a guess on revenue alone—it's AI memory demand....
When Micron announced a Taiwanese site acquisition, micron stock popped today and sparked a broader discussion about ...
A small exodus of California's billionaires ahead of a proposed wealth tax could erase billions in expected revenue. ...
Capgemini’s strategy chief says the idea that AI will eliminate consultants is overstated, arguing transformation wor...